Altaire Recalls Ocusoft Goniosoft Ophthalmic Solution Due to Sterility Concerns
Altaire Pharmaceuticals is recalling Ocusoft Goniosoft Hypromellose 2.5% Ophthalmic Demulcent Solution due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving sterility issues in ophthalmic products which carry significant risk of infection.
Plain-English summary
Altaire Pharmaceuticals, Inc. is recalling Ocusoft Goniosoft Hypromellose 2.5% Ophthalmic Demulcent Solution, 15 mL, manufactured for Ocusoft, Inc. The recall is being conducted because of a lack of assurance of sterility in the product.
The affected product is identified by the NDC 54799-503-15. The recall includes specific lot codes and expiration dates: 16260 (9/19), 17303 (10/20), 18032 (2/21), 18235 (9/21), 18285 (11/21), and 19021 (1/22). The product was distributed nationwide in the United States.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or pharmacist for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Ocusoft Goniosoft Hypromellose 2.5% Opthalmic Demulcent Solution, 15 mL, Manufactured for: Ocusoft, Inc., Richmond, TX 77406-0429, NDC 54799-503-15
- Manufacturer
- Altaire Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 16260 9/19 17303 10/20 18032 2/21 18235 9/21 18285 11/21 19021 1/22
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 134 products in this recall →Related recalls
Same manufacturer · Altaire Pharmaceuticals, Inc.
See all →- SevereCVS Health Dry Eye Relief Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls Equate Support Advanced Twin Pack Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls OCuSOFT Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereCompounded Ophthalmic Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereSpironolactone Ophthalmic Solution Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-09-22
- SevereAzelastine Hydrochloride Ophthalmic Solution Recalled Due to Sterility
FDA (Drugs) · 2025-07-02
- SevereApotex Recalls Latanoprost Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-08-14
- HighVancomycin Ophthalmic Solutions Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2023-02-01
- SevereVancomycin Ophthalmic Solution Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-03-23